FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Alphosyl cream (Haleon UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuleve Maximum Strength 10% gel (Diomed Developments Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten HC cream (Bayer Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuleve 5% gel (Diomed Developments Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Brevoxyl 4% cream (Haleon UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate Eczema and Dermatitis 0.05% cream (Haleon UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Locoid C cream (Yamanouchi Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Efcortelan 0.5% cream (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Magnesium sulphate paste (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermacort hydrocortisone 0.1% cream (Sankyo Pharma UK) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate RD 0.025% cream (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Retin-A 0.01% gel (Janssen-Cilag Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fenbid 5% gel (Goldshield Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten 1% cream (Bayer Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous cream (J M Loveridge Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eurax Hc cream (Thornton & Ross Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Conotrane cream (Evolan Pharma AB) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cuplex gel (Crawford Pharmaceuticals) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Isotrex 0.05% gel (Stiefel Laboratories Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cutivate 0.05% cream (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Trintek 10 transdermal patches (Goldshield Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clinitar 2% shampoo (Cambridge Healthcare supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eurax 10% cream (Thornton & Ross Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transiderm-Nitro 5 transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoconazole 2% shampoo (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoconazole 2% shampoo (Alpharma Limited) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous cream (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Neutrogena T/Gel Therapeutic shampoo (Johnson & Johnson Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% cream (GP Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ecostatin 1% cream (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous calamine cream (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Daktacort ointment (Janssen-Cilag Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat Relief cream (Sankyo Pharma UK) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Naseptin nasal cream (Alliance Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Isotrexin gel (Stiefel Laboratories Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Curatoderm 4micrograms/g ointment (Crookes Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Daktacort HC cream (McNeil Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Adams Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous calamine cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zacin 0.025% cream (Medeus Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betamethasone valerate 0.1% cream (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lamisil AT 1% cream (Haleon UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nerisone 0.1% oily cream (Meadow Laboratories) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Intralgin gel (3M Health Care Ltd, Pharmaceuticals Division) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Panoxyl Acnegel 5 (Stiefel Laboratories Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    NiQuitin CQ 21mg patches (GlaxoSmithKline Consumer Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous cream (Adams Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% ointment (Organon Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fungederm 1% cream (Nucare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat gel (Sankyo Pharma UK) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    NiQuitin CQ 14mg patches (GlaxoSmithKline Consumer Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% ointment (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nurofen 5% gel (Crookes Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Approved Prescription Services) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dalacin 2% cream (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous cream (Alpharma Limited) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clotrimazole 1% cream (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten AF 1% cream (Bayer Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Trintek 5 transdermal patches (Goldshield Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% cream (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Aqueous cream (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fucibet cream (LEO Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoprofen 2.5% gel (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (Accord Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Acticin 0.025% cream (Strakan Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Betnovate RD 0.025% ointment (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% gel (GP Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Propaderm 0.025% ointment (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Synalar 0.025% ointment (GP Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Efudix 5% cream (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Minitran 10 transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Efcortelan 2.5% cream (GlaxoSmithKline) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Algesal cream (Zeroderma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    NiQuitin CQ Clear 14mg patches (GlaxoSmithKline Consumer Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Feldene P 0.5% gel (Pfizer Consumer Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Stiedex LP 0.05% oily cream (Stiefel Laboratories Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Acnecide 5% gel (Galderma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Piroxicam 0.5% gel (Unichem Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Axsain 0.075% cream (Medeus Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nizoral Dandruff 2% shampoo (McNeil Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Tiloket 2.5% gel (Tillomed Laboratories) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoconazole 2% shampoo (Sandoz Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% cream (Organon Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Canesten Hydrocortisone cream (Bayer Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Emulsifying ointment (Kent Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Alphosyl 2 in 1 shampoo (GlaxoSmithKline Consumer Healthcare) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Phor Pain Forte 10% gel (Goldshield Healthcare Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Feldene 0.5% gel (Pfizer Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 10 transdermal patches (Forum Health Products Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fucidin 2% ointment (LEO Pharma) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Nitro-Dur 0.2mg/hour transdermal patches (Organon Pharma (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Movelat cream (Sankyo Pharma UK) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 16 of 55 Next End


    This concept is not in any reference sets

    Back to Start